Home » Topics » Conferences

Conferences
RSS

Potent and selective inhibitors of p56lck kinase developed at Celltech

Sep. 9, 1998

Astra presents data on novel series of cPLA2 inhibitors

Sep. 9, 1998

Radioiodinated phospholipid ether analogues useful for tumor imaging

Sep. 9, 1998

Novel WHI compound inhibits 5-LO translocation in mast cells

Sep. 9, 1998

Glaxo Wellcome describes hypoglycemic activity of PPAR ligand

Sep. 9, 1998

Novel ACAT inhibitors from DuPont Pharmaceuticals debut at ACS meeting

Sep. 9, 1998

DuPont presents XJ-304 and related compounds as ACAT inhibitors at ACS

Sep. 9, 1998

WHI investigators design novel inhibitors of EGF receptor tyrosine kinase

Sep. 9, 1998

Taisho and Nihon Nohyaku describe development of potential new antipsychotics at ACS meeting

Sep. 9, 1998

Lepirudin more effective than heparin in preventing cardiac events in unstable angina

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.